Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, is proud to announce its inclusion on the Inc. 2024 Best in Business list in the Health Products ...

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...

This penchant for calls isn't entirely unusual, given the stock's 50-day call/put volume ratio of 3.55 at the International ...

Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report)’s stock price gapped up prior to trading on Monday after Canaccord Genuity Group raised their price target on the stock from $28.00 to $38.00.

The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that ...

Canaccord raised the firm’s price target on Hims & Hers to $38 from $28 and keeps a Buy rating on the shares. The stock rallied 70% in ...

Panaji: Health minister Vishwajit Rane on Monday said that the super-speciality block (SSB) at Goa Medical College at Bambolim will implement the hosp.

The Washington Post: This Year, Be Thankful For AI In Medicine Artificial intelligence is revolutionizing medicine, making health care more accurate and less expensive for everyone. (11/27) ...

Our advice following last week's rally is for investors to stay with the momentum and manage sentiment-based risk with options ...

On Friday, Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $32.15 which represents a slight increase of $1.81 or 5.97% from the prior close of $30.34. The stock opened at ...

FLW has been speaking with our Cardiff City fan pundit to discuss whether Steve Cooper would be the right man to take charge ...